Why the study?
Does intradermal endothelin reduce local microvascular blood flow in a rabbit skin model?
Does intradermal endothelin reduce local microvascular blood flow in a rabbit skin model?
Endothelin demonstrates potent microvascular vasoconstrictor activity in vivo, suggesting an important role in physiological blood flow and pressure regulation.
Endothelin potently constricts microvasculature in vivo; extends prior in vitro data but leaves human relevance open.
Endothelin is a recently discovered peptide produced by endothelial cells. It has been shown to have potent constrictor effects on major arteries in vitro and to raise rat blood pressure in vivo. The present experiments show that endothelin has a potent constrictor action on the microvasculature. Blood flow changes were measured by a xenon clearance technique in rabbit skin. Endothelin, when injected intradermally into rabbit skin, decreased local blood flow in a dose-dependent manner. Endothelin reduced basal skin blood flow and reversed the increased blood flow induced by a vasodilator. These results show that endothelin, administered extravascularly, has potent vasoconstrictor activity. This adds further support to the suggestion that endothelin may have an important role in the physiological control of blood flow and pressure.
No takes yet. Share an insight, caveat, or question.
Brain et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: